Scientific advisors

Isarna Therapeutics is and was supported by an international team of scientists, researchers, and clinicians who are leading experts in the fields of TGF-β, translational medicine and ophthalmology.


Frank Holz, MD

Chairman and Professor, Department of Ophthalmology, University of Bonn, Germany

Philip J Rosenfeld, MD, Ph.D

Professor, Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, USA

Marco Zarbin, MD

Professor, Director Department of Ophthalmology, New Jersey, USA



Rosemary Akhurst, Ph.D.

Professor and Director of Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, USA

Alon Harris, Ph.D., FARVO

Professor of Ophthalmology, Director of Clinical Research, Professor of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, USA

Ugur Sahin, M.D.

Professor of Experimental Oncology, Founder and Managing Director (Science and Research) of TRON GmbH, Mainz, Germany

David Spalton, M.D.

Professor of Ophthalmology, The London Clinic Eye Centre, London, United Kingdom

Walter Stark, M.D.

Professor of Ophthalmology and Director of the Stark-Mosher Center for Cataract and Corneal Diseases of the Wilmer Eye Institute at the Johns Hopkins Medical Institutions, Johns Hopkins University, Baltimore, USA

Josep Tabernero, M.D.

Professor and Director of Vall d'Hebron Institute of Oncology, Head Medical Oncology Department, Director Clinical Research, Barcelona, Spain

Rohit Varma, M.D.

Professor and Chair of the Department of Ophthalmology at the University of Southern California and Director USC Eye Institute, Keck School of Medicine of USC, Los Angeles, USA

Michael Weller, M.D.

Professor of Neurology, Chairman of the Department of Neurology, University Hospital Zurich, Switzerland

Michael Wormstone, Ph.D.

Faculty Member and Senior Lecturer at the School of Biological Sciences, University of East Anglia, Norwich, United Kingdom